Qrons Inc. QRON
Set alert
As of May 27, 9:30 AM ET
- YTD
- 0.00%
- 1 year
- -93.58%
- Open
- 0.0111
- Prev close
- 0.0111
- Mkt cap
- 199.80K
- Vol
- 100
- Avg vol
- 83
- EPS
- -0.03
- P/E
- -0.37
More statistics
- Low
- 0.0111
- High
- 0.0111
News
2 months ago prnewswire.com
First Person Enters Its Next Phase of Growth Following Early Think Fast™ Momentum
Cognitive performance and functional wellness brand expands its focus across mental readiness, active lifestyles and everyday performance LOS ANGELES, Aug. 18, 2026 /PRNewswire/ -- First Person…
2 years ago accesswire.com
Qrons Announces the Addition of Professor Shiri Navon-Venezia to its Scientific Advisory Board to Beef up its Team, as Part of its New Sepsis Research Program
NEW YORK, NY / ACCESSWIRE / November 20, 2023 / Qrons Inc. (OTCQB:QRON) announced that Professor Shiri Navon-Venezia has agreed to join Qrons Scientific Advisory Board. Professor Venezia is Professor…
3 years ago accesswire.com
Qrons Announces Launch of its New Website in Furtherance of its Neuronal and Infectious Disease Treatments Development, Including Sepsis
NEW YORK, NY / ACCESSWIRE / August 23, 2023 / Qrons Inc. (OTCQB:QRON) an innovative biotechnology company dedicated to developing products treatments and technologies to combat neuronal and…
3 years ago accesswire.com
Qrons Announces the Filing of a Provisional Patent Application in Furtherance of its Neuronal and Infectious Disease Treatments Development, Including Sepsis
NEW YORK, NY / ACCESSWIRE / August 14, 2023 / Qrons Inc. (OTCQB:QRON) an innovative biotechnology company dedicated to developing products to combat neuronal and infectious diseases with a focus on…
3 years ago accesswire.com
Qrons Announces the Signing of a License Agreement Term Sheet as Part of New Research Program to Experiment and Commercialize the Therapeutic Effect of Certain Tellurium Based Compounds on Antibiotic Resistance Bacterial Infections, Sepsis and Traumatic Brain Injuries
NEW YORK, NY / ACCESSWIRE / July 20, 2023 / Qrons Inc. (OTCQB:QRON) announced today the signing of a License Agreement Term Sheet effective July 17, 2023 with Professors Benjamin Sredni & Michael…